SEC Form 4 · accession 0001209191-15-072497
CORCEPT THERAPEUTICS INC · CORT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Anne M LeDoux
Officer — VP & Controller
Period of report
Sep 28, 2015
Accepted (ET)
Sep 29, 2015 · 6:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001088856
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 28, 2015 | M | 25,000 | $1.19 | A | 50,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock optionF2 | $1.19 | Sep 28, 2015 | M | 25,000 | D | — | Mar 26, 2019 | Common stock | 25,000 | 75,000 | D |
Explanation of responses
- F1Exercise and hold.
- F2Fully exerciseable.